FDA Inspection 1115611 — BioLife Plasma Services LP

BioLife Plasma Services LP — FEI 1000143570

The FDA completed an inspection of BioLife Plasma Services LP on December 18, 2019 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 18, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Austin, TX (United States)